EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Design, Synthesis, Antibacterial and Antioxidant Evaluation of Novel 1,2,3-Triazoline Derivatives Bearing benzo[d]isothiazol-3(2H)-one 1,1-dioxide Moiety

Hayder Raheem Ali, Ahmed Wahed Naser

Journal of Fluorescence · 2025

DOI: 10.1007/s10895-025-04431-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Fluorescence, 2025. Verfasst von Hayder Raheem Ali und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, University of Kerbala, Karbala, Iraq. hayder.raheem@uokerbala.edu.iq. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antioxidants, Drug Design, Triazoles. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

1,2,3-triazoline-containing compounds were prepared starting from sodium saccharin salt reacted with allyl chloride to form N- allyl saccharin (1), then reacted with aromatic azides to give compound (2a-g) were hydrolyzed under strong basic conditions to form the carboxylic acid derivative (3a-g). The compounds were identified using analytical and spectral methods [Fourier transform infrared (FT-IR) and some of them 1H-NMR, 13C-NMR] shown in the work. The compounds were tested for their biological and antioxidant activity; some compounds were active and others were not. The recently synthesized fourteen compounds produced positive docking results and suitable binding interactions in molecular docking tests on the target 6ul7(Escherichia coli Dihydrofolate Reductase (DHFR) in complex with a novel inhibitor. Function:Dihydrofolate reductase (DHFR) is an essential enzyme in the folate biosynthesis pathway. It catalyzes the reduction of dihydrofolate to tetrahydrofolate, a critical step in the synthesis of nucleotides and DNA. Due to its importance in cell division, DHFR is a prime target for antimicrobial drugs, such as trimethoprim, which inhibit its activity to disrupt bacterial growth). The current findings show that the recently synthesized compounds have promising Escherichia coli inhibitory efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAntioxidantsDrug DesignTriazolesTetrahydrofolate DehydrogenaseEscherichia coliMolecular Docking SimulationMicrobial Sensitivity TestsStructure-Activity RelationshipBiphenyl CompoundsMolecular Structure

Stichwörter der Autor:innen

1,2,3-TriazolineAntibacterialElectrochemical oxidationMolecular Docking

Substanzen

Anti-Bacterial AgentsAntioxidantsTetrahydrofolate DehydrogenaseTriazolesBiphenyl Compounds

Autor:innen und Institutionen

  • Department of Chemistry, College of Science, University of Kerbala, Karbala, Iraq. hayder.raheem@uokerbala.edu.iq.
  • Department of Chemistry, College of Science, University of Baghdad, Baghdad, Iraq.

Zitieren

APA

Ali, H. R., & Naser, A. W. (2025). Design, Synthesis, Antibacterial and Antioxidant Evaluation of Novel 1,2,3-Triazoline Derivatives Bearing benzo[d]isothiazol-3(2H)-one 1,1-dioxide Moiety. Journal of Fluorescence. https://doi.org/10.1007/s10895-025-04431-7

Vancouver

Ali HR, Naser AW. Design, Synthesis, Antibacterial and Antioxidant Evaluation of Novel 1,2,3-Triazoline Derivatives Bearing benzo[d]isothiazol-3(2H)-one 1,1-dioxide Moiety. Journal of Fluorescence. 2025. doi:10.1007/s10895-025-04431-7

BibTeX
@article{Ali2025,
  author = {Ali, Hayder Raheem and Naser, Ahmed Wahed},
  title = {Design, Synthesis, Antibacterial and Antioxidant Evaluation of Novel 1,2,3-Triazoline Derivatives Bearing benzo[d]isothiazol-3(2H)-one 1,1-dioxide Moiety},
  journal = {Journal of Fluorescence},
  year = {2025},
  doi = {10.1007/s10895-025-04431-7}
}
Kostenlos starten →